BMS chief wins big pay hike following R&D success; Organogenesis wins OK for new therapy; Epistem inks pact with GSK;

@FierceBiotech: Beefed-up aspirin, charged with gas, conquers colon cancer in lab. Item | Follow @FierceBiotech

@JohnCFierce: Hwang Woo-Suk is an oddly compelling character. Convicted in a scandal that would have destroyed anyone, still moving on. Story | Follow @JohnCFierce

@RyanMFierce: FDA advisers back J&J, Pfizer efforts to start testing controversial arthritis pain meds. Story | Follow @RyanMFierce

@FierceMedDev: Consumer Reports taps ire over bad medical devices. News | Follow @FierceMedDev

> Bristol-Myers Squibb ($BMY) chief Lamberto Andreotti is benefiting from the biotech's successful R&D work. The CEO won a 27% increase in total compensation last year, earning $14.9 million. Story

> Organogenesis has won approval for Gintuit, which spurs the development of new gum tissue. Report

> The U.K.'s Epistem has inked a fibrosis research pact with GlaxoSmithKline ($GSK). Report

Pharma News

@FiercePharma: So why would Pfizer walk away from its $200M upfront for the Biocon diabetes deal? Item | Follow @FiercePharma

> Feds reportedly demand $1.8B in Risperdal marketing probe. Item

> After big hike in 2011, GSK CEO's pay set to jump again. News

> AstraZeneca sues FDA to block Seroquel copies. Report

> Pfizer's marketing pact with Biocon falls apart. More

Biotech Research News

> Stem cells end need for anti-rejection meds in some kidney transplant patients. Item

> U.K. research knocks wind out of personalized medicine push. Report

> Antibody blocks advance of Alzheimer's plaque in mice. Story

> Glaucoma-stricken rats see better, thanks to stem cells. Article

> Beefed-up aspirin, charged with gas, conquers colon cancer in lab. News

> RhoGDI2 protein hampers bladder cancer metastasis. Story

Manufacturing News

> Fire at Sandoz plant complicates drug shortages. Item

> Litigation: Sanofi, Genzyme 'negligently allowed a virus contamination in the manufacturing facility.' News

> Loss of manufacturing contract takes toll on Patheon. Report

> U.K. drug regulator asks industry to name the rules it wants to go. Story

> FDA says 5 years of Warner Chilcott's Ovcon BC pills suspect. Item

> WHO joins agencies in beefing up inspections of API facilities. Article

And Finally… Disgraced South Korean scientist Hwang Woo-Suk has enlisted in an effort to clone the woolly mammoth, which has been extinct for thousands of years. Story